Abstract

Brain-derived neurotrophic factor (BDNF) plays a central pivotal role in the development of the cardiovascular system. Recent evidence suggests that BDNF has adverse subclinical cardiac remodeling in participants with cardiovascular disease risk factors. Relating serum BDNF levels with two-dimensional echocardiographic indices will provide insights into the BDNF mediated pathophysiology in coronary artery disease (CAD) that may shed light upon potential diagnostic biomarkers. For the study, 221 participants were recruited and classified based on coronary angiogram examination as control (n = 105) and CAD (n = 116). All participants underwent routine blood investigation, two-dimensional echocardiography, and serum BDNF estimation. As a result, total cholesterol, triglyceride, low-density lipid, high-density lipid, HbA1c (glycosylated hemoglobin), serum creatinine, eosinophils, lymphocyte, monocytes, neutrophils, and platelets were significantly elevated in CAD individuals compared to controls. Notably, the serum BDNF was significantly lower in individuals with CAD (30.69 ± 5.45 ng/ml) than controls (46.58 ± 7.95 ng/ml). Multivariate regression analysis showed neutrophils, total cholesterol, left ventricular mass index, mitral inflow E/A ratio, and pulmonary vein AR duration were associated with low BDNF in CAD. Four independent support vector machine (SVM) models performed to ensure the BDNF level in the classification of CAD from healthy controls. Particularly, the model with serum BDNF concentration and blood parameters of CAD achieved significant improvement from 90.95 to 98.19% in detecting CAD from healthy controls. Overall, our analysis provides a significant molecular linkage between the serum BDNF level and cardiovascular function. Our results contribute to the emerging evidence of BDNF as a potential diagnostic value in CAD that might lead to clinical application.

Highlights

  • Brain-derived neurotrophic factor (BDNF) plays a central pivotal role in the development of the cardiovascular system

  • The statistical t-test analysis showed a significant change in BMI, platelet, eosinophils, lymphocyte, monocytes, neutrophils, HbA1c, serum creatinine, low density lipid (LDL), high density lipid (HDL), triglyceride (TGL), and total cholesterol in coronary artery disease (CAD) compared to control (Table 1)

  • The analysis suggests low BDNF concentration is the measure of both blood and echocardiographic indices (LVMI, MV E/A, pulmonary vein AR duration (PV AR), and Biplane left ventricular ejection fraction (LVEF)) in CAD

Read more

Summary

Introduction

Brain-derived neurotrophic factor (BDNF) plays a central pivotal role in the development of the cardiovascular system. Recent evidence suggests that BDNF has adverse subclinical cardiac remodeling in participants with cardiovascular disease risk factors. Relating serum BDNF levels with two-dimensional echocardiographic indices will provide insights into the BDNF mediated pathophysiology in coronary artery disease (CAD) that may shed light upon potential diagnostic biomarkers. Relating serum BDNF levels with echocardiographic indices may provide the involvement of BDNF in cardiac systems, which may be useful in developing a potential alternative method for CAD diagnosis. Bahls et al, 2019 showed the association between low BDNF and echocardiographic indices in participants with traditional risk factors of future C­ AD17. The role of BDNF with cardiac left ventricular function and its ability to classify CAD from healthy controls is less well known

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call